
Portable Bioprocessing Bioreactors Market- Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032
Description
Market Overview
The Portable Bioprocessing Bioreactors Market was valued at USD 1,735 million in 2024 and is projected to reach USD 5,089.88 million by 2032, growing at a robust compound annual growth rate (CAGR) of 14.4% during the forecast period (2024–2032).
This growth is primarily attributed to the increasing preference for flexible, scalable, and cost-efficient bioprocessing solutions. Portable bioreactors enhance operational performance by reducing contamination risk, improving process control, and enabling efficient workflows—making them highly suitable for biopharmaceutical production, regenerative medicine, and advanced research applications. The surge in demand for cell and gene therapies, along with monoclonal antibodies (mAbs), is further accelerating the need for advanced bioreactor systems. Moreover, the widespread adoption of single-use bioprocessing technologies is significantly supporting market expansion by offering advantages such as reduced downtime, lower maintenance expenses, and enhanced sterility. The growing role of contract development and manufacturing organizations (CDMOs) in biopharmaceutical manufacturing is also contributing to market momentum, as these entities seek agile and scalable production solutions to meet evolving industry demands.
Market Drivers
Increasing Adoption of Single-Use Technologies
The market is being positively influenced by the rising integration of single-use systems in bioprocessing operations. Over the past five years, the implementation of single-use technologies in biopharmaceutical manufacturing has grown by approximately 15%. These systems reduce contamination risks, streamline cleaning protocols, and minimize operational downtime—making them an attractive solution for manufacturers aiming to optimize efficiency and cost-effectiveness. The deployment of disposable bioreactor bags and modular process units supports sterile operations while enhancing process flexibility, thereby driving widespread adoption across various bioprocessing facilities.
Market Challenges Analysis
Shortage of Skilled Workforce
A significant hurdle in the expansion of portable bioprocessing systems is the limited availability of skilled personnel. According to the Department of Labour, over 200 hours of initial training and ongoing quarterly updates are required for proficiency in this field. This presents a major challenge, especially in emerging markets where bioprocessing expertise is limited. The skills gap not only slows technology integration but also hinders productivity gains, necessitating increased investments in workforce development and automation technologies. Furthermore, the operational costs associated with portable bioreactors—combined with extended timelines for regulatory validation and system installation (typically ranging from 6 to 18 months)—pose additional constraints. Compliance with stringent Environmental Protection Agency (EPA) protocols for cleaning and waste disposal also increases the complexity and cost of operations, as facilities are required to implement advanced cleaning-in-place (CIP) and sterilization-in-place (SIP) systems.
Market Segmentation
By Capacity:
1 to 10 Litres
10 to 50 Litres
50 to 100 Litres
100 to 500 Litres
By Material:
Glass
Stainless Steel
Single-Use
By End User:
Biopharmaceutical Industry
Academic Institutes
Research Laboratories
By Region:
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Southeast Asia
Rest of Asia Pacific
Latin America
Brazil
Argentina
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of Middle East and Africa
Key Player Analysis
Sartorius AG
Thermo Fisher Scientific, Inc.
Merck KGaA
Eppendorf AG
Danaher Corporation
Applikon Biotechnology (Getinge)
Solaris Biotech
Pall Corporation
Pierre Guerin (Engie Group)
Infors HT
The Portable Bioprocessing Bioreactors Market was valued at USD 1,735 million in 2024 and is projected to reach USD 5,089.88 million by 2032, growing at a robust compound annual growth rate (CAGR) of 14.4% during the forecast period (2024–2032).
This growth is primarily attributed to the increasing preference for flexible, scalable, and cost-efficient bioprocessing solutions. Portable bioreactors enhance operational performance by reducing contamination risk, improving process control, and enabling efficient workflows—making them highly suitable for biopharmaceutical production, regenerative medicine, and advanced research applications. The surge in demand for cell and gene therapies, along with monoclonal antibodies (mAbs), is further accelerating the need for advanced bioreactor systems. Moreover, the widespread adoption of single-use bioprocessing technologies is significantly supporting market expansion by offering advantages such as reduced downtime, lower maintenance expenses, and enhanced sterility. The growing role of contract development and manufacturing organizations (CDMOs) in biopharmaceutical manufacturing is also contributing to market momentum, as these entities seek agile and scalable production solutions to meet evolving industry demands.
Market Drivers
Increasing Adoption of Single-Use Technologies
The market is being positively influenced by the rising integration of single-use systems in bioprocessing operations. Over the past five years, the implementation of single-use technologies in biopharmaceutical manufacturing has grown by approximately 15%. These systems reduce contamination risks, streamline cleaning protocols, and minimize operational downtime—making them an attractive solution for manufacturers aiming to optimize efficiency and cost-effectiveness. The deployment of disposable bioreactor bags and modular process units supports sterile operations while enhancing process flexibility, thereby driving widespread adoption across various bioprocessing facilities.
Market Challenges Analysis
Shortage of Skilled Workforce
A significant hurdle in the expansion of portable bioprocessing systems is the limited availability of skilled personnel. According to the Department of Labour, over 200 hours of initial training and ongoing quarterly updates are required for proficiency in this field. This presents a major challenge, especially in emerging markets where bioprocessing expertise is limited. The skills gap not only slows technology integration but also hinders productivity gains, necessitating increased investments in workforce development and automation technologies. Furthermore, the operational costs associated with portable bioreactors—combined with extended timelines for regulatory validation and system installation (typically ranging from 6 to 18 months)—pose additional constraints. Compliance with stringent Environmental Protection Agency (EPA) protocols for cleaning and waste disposal also increases the complexity and cost of operations, as facilities are required to implement advanced cleaning-in-place (CIP) and sterilization-in-place (SIP) systems.
Market Segmentation
By Capacity:
1 to 10 Litres
10 to 50 Litres
50 to 100 Litres
100 to 500 Litres
By Material:
Glass
Stainless Steel
Single-Use
By End User:
Biopharmaceutical Industry
Academic Institutes
Research Laboratories
By Region:
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Southeast Asia
Rest of Asia Pacific
Latin America
Brazil
Argentina
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of Middle East and Africa
Key Player Analysis
Sartorius AG
Thermo Fisher Scientific, Inc.
Merck KGaA
Eppendorf AG
Danaher Corporation
Applikon Biotechnology (Getinge)
Solaris Biotech
Pall Corporation
Pierre Guerin (Engie Group)
Infors HT
Table of Contents
200 Pages
- CHAPTER NO. 1 : INTRODUCTION
- 1.1.1. Report Description
- Purpose of the Report
- USP & Key Offerings
- 1.1.2. Key Benefits for Stakeholders
- 1.1.3. Target Audience
- 1.1.4. Report Scope
- CHAPTER NO. 2 : EXECUTIVE SUMMARY
- 2.1. Portable Bioprocessing Bioreactors Market Snapshot
- 2.1.1. Portable Bioprocessing Bioreactors Market, 2018 - 2032 (USD Million)
- CHAPTER NO. 3 : Portable Bioprocessing Bioreactors Market – INDUSTRY ANALYSIS
- 3.1. Introduction
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Market Opportunities
- 3.5. Porter’s Five Forces Analysis
- CHAPTER NO. 4 : ANALYSIS COMPETITIVE LANDSCAPE
- 4.1. Company Market Share Analysis – 2023
- 4.2. Portable Bioprocessing Bioreactors Market Company Revenue Market Share, 2023
- 4.3. Company Assessment Metrics, 2023
- 4.4. Start-ups / SMEs Assessment Metrics, 2023
- 4.5. Strategic Developments
- 4.6. Key Players Product Matrix
- CHAPTER NO. 5 : PESTEL & ADJACENT MARKET ANALYSIS
- CHAPTER NO. 6 : Portable Bioprocessing Bioreactors Market – BY Based on Capacity: ANALYSIS
- CHAPTER NO. 7 : Portable Bioprocessing Bioreactors Market – BY Based on material: ANALYSIS
- CHAPTER NO. 8 : Portable Bioprocessing Bioreactors Market – BY Based on End User: ANALYSIS
- CHAPTER NO. 9 : Portable Bioprocessing Bioreactors Market – BY Based on Region: ANALYSIS
- CHAPTER NO. 10 : COMPANY PROFILES
- 10.1. Sartorius AG
- 10.1.1. Company Overview
- 10.1.2. Product Portfolio
- 10.1.3. SWOT Analysis
- 10.1.4. Business Strategy
- 10.1.5. Financial Overview
- 10.2. Thermo Fisher Scientific, Inc.
- 10.3. Merck KGaA
- 10.4. Eppendorf AG
- 10.5. Danaher Corporation
- 10.6. Applikon Biotechnology (Getinge)
- 10.7. Solaris Biotech
- 10.8. Pall Corporation
- 10.9. Pierre Guerin (Engie Group)
- 10.10. Infors HT
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.